These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 194397)

  • 1. Studies on the in vitro uncoating of poliovirus. II. Characteristics of the membrane-modified particle.
    De Sena J; Mandel B
    Virology; 1977 May; 78(2):554-66. PubMed ID: 194397
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the in vitro uncoating of poliovirus. III. Roles of membrane-modifying and -stabilizing factors in the generation of subviral particles.
    De Sena J; Torian B
    Virology; 1980 Jul; 104(1):149-63. PubMed ID: 6249022
    [No Abstract]   [Full Text] [Related]  

  • 3. A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay.
    Guttman N; Baltimore D
    Virology; 1977 Oct; 82(1):25-36. PubMed ID: 197703
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the in vitro uncoating of poliovirus. I. Characterization of the modifying factor and the modifying reaction.
    De Sena J; Mandel B
    Virology; 1976 Apr; 70(2):470-83. PubMed ID: 4921
    [No Abstract]   [Full Text] [Related]  

  • 5. Involvement of viral procapsid in the RNA synthesis and maturation of poliovirus.
    Yin FH
    Virology; 1977 Oct; 82(2):299-307. PubMed ID: 199991
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and biological characteristics of carbethoxylated poliovirus and viral RNA.
    Oberg B
    Biochim Biophys Acta; 1970 Apr; 204(2):430-40. PubMed ID: 4315015
    [No Abstract]   [Full Text] [Related]  

  • 7. Poliovirus morphogenesis. I. Identification of 80S dissociable particles and evidence for the artifactual production of procapsids.
    Marongiu ME; Pani A; Corrias MV; Sau M; La Colla P
    J Virol; 1981 Aug; 39(2):341-7. PubMed ID: 6268826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro assembly of polioviruses. I. Kinetics of the assembly of empty capsids and the role of extracts from infected cells.
    Phillips BA
    Virology; 1969 Dec; 39(4):811-21. PubMed ID: 4311640
    [No Abstract]   [Full Text] [Related]  

  • 9. Competence of suspended HeLa cells for infection by inactivated poliovirus particles and by isolated viral RNA.
    Breindl M; Koch G
    Virology; 1972 Apr; 48(1):136-44. PubMed ID: 4335931
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus coat protein as the site of guanidine action.
    Korant BD
    Virology; 1977 Aug; 81(1):25-36. PubMed ID: 196400
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of type 1 poliovirus by electrophoretic analysis.
    Mandel B
    Virology; 1971 Jun; 44(3):554-68. PubMed ID: 4332969
    [No Abstract]   [Full Text] [Related]  

  • 12. The formation of poliovirus particles in association with the RNA replication complexes.
    Caliguiri LA; Compans RW
    J Gen Virol; 1973 Oct; 21():99-108. PubMed ID: 4357379
    [No Abstract]   [Full Text] [Related]  

  • 13. Cleavage of viral precursor proteins in vivo and in vitro.
    Korant BD
    J Virol; 1972 Oct; 10(4):751-9. PubMed ID: 4343549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early alteration of poliovirus in infected cells and its specific inhibition.
    Lonberg-Holm K; Gosser LB; Kauer JC
    J Gen Virol; 1975 Jun; 27(3):329-42. PubMed ID: 167116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myristate modification does not function as a membrane association signal during poliovirus capsid assembly.
    Lee YM; Chow M
    Virology; 1992 Apr; 187(2):814-20. PubMed ID: 1312279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
    González ME; Almela MJ; Yacout M; Carrasco L
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1259-61. PubMed ID: 2168147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poliovirus infection without accumulation of eclipse particles.
    Ofori-Anyinam O; Vrijsen R; Kronenberger P; Boeyé A
    Antiviral Res; 1995 Jan; 26(1):27-35. PubMed ID: 7741519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncoating-like modification of poliovirus capsid resulting from the cooperative effects of subfreezing temperature and submolar concentrations of urea.
    Mandel B
    Arch Virol; 1982; 71(1):27-42. PubMed ID: 6279054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating.
    Asare E; Mugavero J; Jiang P; Wimmer E; Paul AV
    J Virol; 2016 Jul; 90(14):6174-6186. PubMed ID: 27076638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
    Dove AW; Racaniello VR
    J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.